Vice President, Intellectual Property and Legal Affairs
Rebecca joined Tessera in October 2021 with over 15 years of legal experience in the biotechnology and pharmaceutical industry, where she’s developed and enforced intellectual property rights protecting biologics in neuroscience, ophthalmology, immunology, and infectious diseases.
Dr. Wais previously served at Genentech as Director and Assistant General Counsel, where she built a global intellectual property strategy for products and platform technologies, overseeing the global IP strategy for Alzheimer’s disease.
Dr. Wais earned her J.D. from Stanford Law School as well as her Ph.D. in Biological Sciences from Stanford University.